Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: Identification of risk factors

Clinical Research in Cardiology

Volumn 98, Issue 4, 2009, Pages 208-212

  Letsas, Konstantinos P ^a   Efremidis, Michalis ^a   Kounas, Stavros P ^a   Pappas, Loukas K ^a   Gavrielatos, Gerasimos ^a   Alexanian, Ioannis P ^a   Dimopoulos, Nikolaos P ^b   Filippatos, Gerasimos S ^a   Sideris, Antonios ^a   Kardaras, Fotis ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

^b Psychiatric Hospital of Attika Dafni   (Greece)

Author keywords

Acquired long QT interval; Cardiac arrest; Drug therapy; Risk factors; Torsade de pointes

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; CIPROFLOXACIN; CITALOPRAM; CLARITHROMYCIN; CLOMIPRAMINE; CYTOCHROME P450; DIGOXIN; ERYTHROMYCIN; GLIBENCLAMIDE; INDAPAMIDE; METRONIDAZOLE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RIVASTIGMINE; SOTALOL; VALPROIC ACID; VENLAFAXINE; ZIPRASIDONE; ZOLPIDEM;

ADULT; AGED; AGING; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; ELECTROCARDIOGRAPHY MONITORING; ENZYME INHIBITION; FEMALE; GENDER; HEART ARREST; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MALE; PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA; PROGNOSIS; QT INTERVAL; QT PROLONGATION; RESUSCITATION; RISK FACTOR; TORSADE DES POINTES; TRANSTHORACIC ECHOCARDIOGRAPHY; VALVULAR HEART DISEASE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTI-ARRHYTHMIA AGENTS; ANTI-BACTERIAL AGENTS; ANTIPSYCHOTIC AGENTS; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; ECHOCARDIOGRAPHY; FEMALE; HEART ARREST; HUMANS; HYPERTENSION; LONG QT SYNDROME; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; SEX FACTORS; TACHYCARDIA, PAROXYSMAL; TORSADES DE POINTES;

EID: 63449140005     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-008-0741-y     Document Type: Article

References (22)

1. A Algra JG Tijssen JR Roelandt J Pool J Lubsen 1991 QTc prolongation measured by standard 12-lead electrocardiography is an independent risk factor for sudden death due to cardiac arrest Circulation 83 1888 1894
2. MM Bednar EP Harrigan JN Ruskin 2002 Torsades de pointes associated with nonantiarrhythmic drugs and observations on gender and QTc Am J Cardiol 89 1316 1319
3. B Chatterjee U Burgi 2006 Syncope of a drug addict-a special case Clin Res Cardiol 95 557 559
4. MD Drici N Clement 2001 Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome Drug Saf 24 575 585
5. RM Gowda IA Khan SL Wilbur BC Vasavada TJ Sacchi 2004 Torsade de pointes: the clinical considerations Int J Cardiol 96 1 6
6. EK Heist JN Ruskin 2005 Drug-induced proarrhythmia and use of QTc-prolonging agents: clues for clinicians Heart Rhythm 2 S1 S8
7. S Kaab A Pfeufer M Hinterseer M Nabauer E Schulze-Bahr 2004 Long QT syndrome. Why does sex matter? Z Kardiol 93 641 645
8. PJ Kannankeril DM Roden 2007 Drug-induced long QT and torsade de pointes: recent advances Curr Opin Cardiol 22 39 43
9. IA Khan 2002 Clinical and therapeutic aspects of congenital and acquired long QT syndrome Am J Med 112 58 66
10. MH Lehmann S Hardy D Archibald B Quart DJ MacNeil 1996 Sex difference in risk of torsade de pointes with d, l-sotalol Circulation 94 2535 2541
11. KP Letsas IP Alexanian LK Pappas SP Kounas M Efremidis A Sideris F Kardaras 2006 QT interval prolongation and torsade de pointes associated with indapamide Int J Cardiol 112 373 374
12. K Ohyama M Nakajima M Suzuki N Shimada H Yamazaki T Yokoi 2000 Inhibitory effects of amiodarone and its N-deethylated metabolite on human cytochrome P450 activities: prediction of in vivo drug interactions Br J Clin Pharmacol 49 244 253
13. A Pfeufer S Jalilzadeh S Perz JC Mueller M Hinterseer T Illig M Akyol C Huth A Schopfer-Wendels B Kuch G Steinbeck R Holle M Nabauer HE Wichmann T Meitinger S Kaab 2005 Common variants in myocardial ion channel genes modify the QT interval in the general population: results from the KORA study Circ Res 96 693 701
14. SG Priori C Napolitano 2002 Genetic defects of cardiac ion channels. The hidden substrate for torsades de pointes Cardiovasc Drugs Ther 16 89 92
15. SG Priori PJ Schwartz C Napolitano R Bloise E Ronchetti M Grillo A Vicentini C Spazzolini J Nastoli G Bottelli R Folli D Cappelletti 2003 Risk stratification in the long-QT syndrome N Engl J Med 348 1866 1874
16. DM Roden 2004 Drug-induced prolongation of the QT interval N Engl J Med 350 1013 1022
17. B Rosati M Rocchetti A Zaza E Wanke 1998 Sulfonylureas blockade of neural and cardiac HERG channels FEBS Lett 440 125 130
18. SM Straus MC Sturkenboom GS Bleumink JP Dieleman J van der Lei PA de Graeff JH Kingma BH Stricker 2005 Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death Eur Heart J 26 2007 2012
19. JM van Opstal M Schoenmakers SC Verduyn SH de Groot JD Leunissen FF van Der Hulst MM Molenschot HJ Wellens MA Vos 2001 Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome Circulation 104 2722 2727
20. Wang 2006 J Pharmacol Exp Ther PMID 17095614
21. YG Yap AJ Camm 2003 Drug induced QT prolongation and torsades de pointes Heart 89 1363 1372
22. D Zeltser D Justo A Halkin V Prokhorov K Heller S Viskin 2003 Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors Medicine (Baltimore) 82 282 290